The price of USPH is predicted to go up 6.73%, based on the high correlation periods with CNO. The similarity of these two price pattern on the periods is 93.07%.
USPH
CNO
Up: 6.73%Similarity: 93.07%
USPH Revenue Forecast
USPH EPS Forecast
USPH FAQs
What is bull’s view on USPH?
USPH stock is currently trading at $93.27, with analysts setting a bullish price target of $113, reflecting an 18% upside. This optimism is driven by USPH's unique partnership model, strong revenue growth potential, and focus on workplace injury prevention, despite challenges like rising labor costs and Medicare reimbursement cuts. Additionally, the end of Medicare rate reductions in 2025 could further enhance growth prospects.
What is bear's view on USPH?
USPH stock is currently trading at $88.71, down from its recent highs. Bears argue that rising labor costs and ongoing Medicare reimbursement cuts could pressure margins, especially in a competitive rehabilitation market. Additionally, the stock's volatility (32%) and lack of significant near-term catalysts suggest limited upside in the short term.
What is USPH revenue forecast for next quarter?
The market consensus for USPH's revenue in the upcoming quarter is projected to be approximately $175.49M USD.
What is USPH eps forecast for next quarter?
The market consensus for USPH's eps in the upcoming quarter is projected to be approximately $0.517 USD.
BofA downgraded U.S. Physical Therapy to Neutral from Buy with a price target of $90, down from $114. The firm likes the "solid" long-term growth profile, but worries about the recent spike in labor combined with a slow denovo ramp, the analyst tells investors. In addition, a slowing economy could impact demand and payor mix and keep the multiple compressed given U.S. Physical's exposure to commercial payors, the analyst contends.